IVX 33.3% 0.2¢ invion limited

The relative five-year survival rate for ovarian cancer is 46.5...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,331 Posts.
    lightbulb Created with Sketch. 436
    The relative five-year survival rate for ovarian cancer is 46.5 percent. Survival rates vary greatly depending on the stage of diagnosis. Women diagnosed at an early stage—before the cancer has spread—have a much higher five-year survival rate than those diagnosed at a later stage.

    terrible type of cancer so with our licenced product hopefully we can increase the above survival rates globally Boom !
 
watchlist Created with Sketch. Add IVX (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $20.29M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $7.612K 3.753M

Buyers (Bids)

No. Vol. Price($)
7 5729449 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 12383990 52
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.